Erratum. Mediterranean Diet, Retinopathy, Nephropathy, and Microvascular Diabetes Complications: A Post Hoc Analysis of a Randomized Trial. Diabetes Care 2015;38:2134-2141.
作者信息
Díaz-López Andrés, Babio Nancy, Martínez-González Miguel A, Corella Dolores, Amor Antonio J, Fitó Montse, Estruch Ramon, Arós Fernando, Gómez-Gracia Enrique, Fiol Miquel, Lapetra José, Serra-Majem Lluís, Basora Josep, Basterra-Gortari F Javier, Zanon-Moreno Vicente, Ángel Muñoz Miguel, Salas-Salvadó Jordi
出版信息
Diabetes Care. 2018 Oct;41(10):2260-2261. doi: 10.2337/dc18-er10a. Epub 2018 Aug 13.
Abstract
摘要
相似文献
1
Erratum. Mediterranean Diet, Retinopathy, Nephropathy, and Microvascular Diabetes Complications: A Post Hoc Analysis of a Randomized Trial. Diabetes Care 2015;38:2134-2141.勘误。地中海饮食、视网膜病变、肾病与糖尿病微血管并发症：一项随机试验的事后分析。《糖尿病护理》2015年；38卷：2134 - 2141页。
Diabetes Care. 2018 Oct;41(10):2260-2261. doi: 10.2337/dc18-er10a. Epub 2018 Aug 13.
2
Improving microvascular outcomes in patients with diabetes through management of hypertension.通过控制高血压改善糖尿病患者的微血管结局。
Postgrad Med. 2009 Mar;121(2):89-101. doi: 10.3810/pgm.2009.03.1980.
3
Erratum to: Microvascular effects of glucagon-like peptide-1 receptor agonists in type 2 diabetes: a meta-analysis of randomized controlled trials.《胰高血糖素样肽-1受体激动剂对2型糖尿病微血管的影响：随机对照试验的荟萃分析》勘误
Acta Diabetol. 2017 Nov;54(11):1069-1071. doi: 10.1007/s00592-017-1049-z.
4
Prevalence and risk factors for diabetic microvascular complications in newly diagnosed type II diabetes mellitus. Sankara Nethralaya Diabetic Retinopathy Epidemiology and Molecular Genetic Study (SN-DREAMS, report 27).新诊断的 2 型糖尿病患者中糖尿病微血管并发症的患病率及其危险因素。Sankara Nethralaya 糖尿病视网膜病变流行病学和分子遗传学研究（SN-DREAMS，报告 27）。
J Diabetes Complications. 2012 Mar-Apr;26(2):123-8. doi: 10.1016/j.jdiacomp.2012.02.001. Epub 2012 Mar 24.
5
Novel therapeutic approaches for diabetic nephropathy and retinopathy.治疗糖尿病肾病和视网膜病变的新方法。
Pharmacol Res. 2015 Aug;98:39-44. doi: 10.1016/j.phrs.2014.10.003. Epub 2014 Oct 29.
6
Microvascular effects of glucagon-like peptide-1 receptor agonists in type 2 diabetes: a meta-analysis of randomized controlled trials.胰高血糖素样肽-1 受体激动剂在 2 型糖尿病中的微血管作用：一项随机对照试验的荟萃分析。
Acta Diabetol. 2017 Oct;54(10):933-941. doi: 10.1007/s00592-017-1031-9. Epub 2017 Jul 27.
7
Effectiveness and safety of basal supported oral therapy with insulin glargine, in Japanese insulin-naive, type 2 diabetes patients, with or without microvascular complications: subanalysis of the observational, non-interventional, 24-week follow-up Add-on Lantus® to Oral Hypoglycemic Agents (ALOHA) study.在日本初治2型糖尿病患者中，无论有无微血管并发症，基础胰岛素甘精胰岛素支持的口服治疗的有效性和安全性：观察性、非干预性、24周随访的口服降糖药加用来得时®（ALOHA）研究的亚分析。
J Diabetes Complications. 2015 Jan-Feb;29(1):127-33. doi: 10.1016/j.jdiacomp.2014.09.012. Epub 2014 Sep 28.
8
Advanced glycation end products assessed by skin autofluorescence in type 1 diabetics are associated with nephropathy, but not retinopathy.皮肤自体荧光评估的 1 型糖尿病患者晚期糖基化终产物与肾病相关，但与视网膜病变无关。
Diabetes Metab. 2010 Apr;36(2):152-7. doi: 10.1016/j.diabet.2009.11.003. Epub 2010 Feb 6.
9
Erratum. Reduction in the Incidence of Type 2 Diabetes With the Mediterranean Diet: Results of the PREDIMED-Reus nutrition intervention randomized trial. Diabetes Care 2011;34:14-19.勘误。地中海饮食可降低2型糖尿病发病率：PREDIMED-Reus营养干预随机试验结果。《糖尿病护理》2011年；34卷：14 - 19页。
Diabetes Care. 2018 Oct;41(10):2259-2260. doi: 10.2337/dc18-er10. Epub 2018 Aug 13.
10
Association of serum adiponectin with diabetic microvascular complications among south Indian type 2 diabetic subjects - (CURES-133).南印度2型糖尿病患者血清脂联素与糖尿病微血管并发症的关联研究（CURES-133）
Clin Biochem. 2015 Jan;48(1-2):33-8. doi: 10.1016/j.clinbiochem.2014.10.009. Epub 2014 Oct 30.
引用本文的文献
1
Adherence to a Healthy Lifestyle in Association With Microvascular Complications Among Adults With Type 2 Diabetes.2 型糖尿病患者的健康生活方式依从性与微血管并发症的关系。
JAMA Netw Open. 2023 Jan 3;6(1):e2252239. doi: 10.1001/jamanetworkopen.2022.52239.
2
Experimental Outcomes of the Mediterranean Diet: Lessons Learned from the Predimed Randomized Controlled Trial.地中海饮食的实验结果：来自 PREDIMED 随机对照试验的经验教训。
Nutrients. 2019 Dec 6;11(12):2991. doi: 10.3390/nu11122991.
Zotero 插件